Skip to main content

Macular Telangiectasia Type 2

4
Pipeline Programs
1
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
2
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Neurotech Pharmaceuticals
4 programs
2
2
NT-501Phase 31 trial
NT-501 CNTF ImplantPhase 31 trial
Ciliary neurotrophic factorPhase 21 trial
NT-501 CNTF implantPhase 21 trial
Active Trials
NCT01949324Completed67Est. May 2017
NCT04729972Completed33Est. Dec 2022
NCT03319849Completed119Est. Sep 2022
+1 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Neurotech PharmaceuticalsNT-501 CNTF Implant
Neurotech PharmaceuticalsNT-501
Neurotech PharmaceuticalsNT-501 CNTF implant
Neurotech PharmaceuticalsCiliary neurotrophic factor

Clinical Trials (4)

Total enrollment: 231 patients across 4 trials

NCT06397131Neurotech PharmaceuticalsNT-501 CNTF Implant

A Study to Determine the Safety and Efficacy of NT-501 With MHFM

Start: Mar 2025Est. completion: Jul 202612 patients
Phase 3Active Not Recruiting
NCT03319849Neurotech PharmaceuticalsNT-501

A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol B

Start: Jan 2018Est. completion: Sep 2022119 patients
Phase 3Completed
NCT04729972Neurotech PharmaceuticalsNT-501 CNTF implant

Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2

Start: Jul 2021Est. completion: Dec 202233 patients
Phase 2Completed
NCT01949324Neurotech PharmaceuticalsCiliary neurotrophic factor

A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel

Start: Apr 2014Est. completion: May 201767 patients
Phase 2Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 late-stage (Phase 3) programs, potential near-term approvals
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.